These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25972494)

  • 1. Screening with MRI for Accurate and Rapid Stroke Treatment: SMART.
    Shah S; Luby M; Poole K; Morella T; Keller E; Benson RT; Lynch JK; Nadareishvili Z; Hsia AW
    Neurology; 2015 Jun; 84(24):2438-44. PubMed ID: 25972494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a 1-year quality-improvement process to reduce door-to-needle time in acute ischemic stroke with MRI screening.
    Sablot D; Gaillard N; Colas C; Smadja P; Gely C; Dutray A; Bonnec JM; Jurici S; Farouil G; Ferraro-Allou A; Jantac M; Allou T; Pujol C; Olivier N; Laverdure A; Fadat B; Mas J; Dumitrana A; Garcia Y; Touzani H; Perucho P; Moulin T; Richard C; Heroum C; Bouly S; Sagnes-Raffy C; Heve D
    Rev Neurol (Paris); 2017; 173(1-2):47-54. PubMed ID: 28131535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke.
    Lin CB; Cox M; Olson DM; Britz GW; Constable M; Fonarow GC; Schwamm L; Peterson ED; Shah BR
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26201547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target Door-to-Needle Time for Tissue Plasminogen Activator Treatment with Magnetic Resonance Imaging Screening Can Be Reduced to 45 min.
    Sablot D; Ion I; Khlifa K; Farouil G; Leibinger F; Gaillard N; Laverdure A; Bensalah ZM; Mas J; Fadat B; Smadja P; Ferraro-Allou A; Bonnec JM; Olivier N; Dutray A; Tardieu M; Dumitrana A; Guibal A; Jurici S; Bertrand JL; Allou T; Arquizan C; Bonafe A
    Cerebrovasc Dis; 2018; 45(5-6):245-251. PubMed ID: 29843148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017.
    Tong X; Wiltz JL; George MG; Odom EC; Coleman King SM; Chang T; Yin X; ; Merritt RK
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004981. PubMed ID: 30557047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
    Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
    Sauser K; Levine DA; Nickles AV; Reeves MJ
    JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timely Reperfusion in Stroke and Myocardial Infarction Is Not Correlated: An Opportunity for Better Coordination of Acute Care.
    Sauser Zachrison K; Levine DA; Fonarow GC; Bhatt DL; Cox M; Schulte P; Smith EE; Suter RE; Xian Y; Schwamm LH
    Circ Cardiovasc Qual Outcomes; 2017 Mar; 10(3):. PubMed ID: 28283469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.
    Lin CB; Peterson ED; Smith EE; Saver JL; Liang L; Xian Y; Olson DM; Shah BR; Hernandez AF; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):514-22. PubMed ID: 22787065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between MRI screening and CT-plus-MRI screening for thrombolysis within 3 h of ischemic stroke.
    Yoo SH; Kwon SU; Lee DH; Kim SJ; Kim JS; Kang DW
    J Neurol Sci; 2010 Jul; 294(1-2):119-23. PubMed ID: 20441993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional Learning Collaboratives Produce Rapid and Sustainable Improvements in Stroke Thrombolysis Times.
    Prabhakaran S; Lee J; O'Neill K
    Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):585-92. PubMed ID: 27625405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24/7 Neurocritical Care Nurse Practitioner Coverage Reduced Door-to-Needle Time in Stroke Patients Treated with Tissue Plasminogen Activator.
    Moran JL; Nakagawa K; Asai SM; Koenig MA
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1148-1152. PubMed ID: 26907680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streamlined Hyperacute Magnetic Resonance Imaging Protocol Identifies Tissue-Type Plasminogen Activator-Eligible Stroke Patients When Clinical Impression Is Stroke Mimic.
    Goyal MS; Hoff BG; Williams J; Khoury N; Wiesehan R; Heitsch L; Panagos P; Vo KD; Benzinger T; Derdeyn CP; Lee JM; Ford AL
    Stroke; 2016 Apr; 47(4):1012-7. PubMed ID: 26892282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke.
    Xian Y; Smith EE; Zhao X; Peterson ED; Olson DM; Hernandez AF; Bhatt DL; Saver JL; Schwamm LH; Fonarow GC
    Stroke; 2014 May; 45(5):1387-95. PubMed ID: 24713527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple text-messaging intervention is associated with improved door-to-needle times for acute ischemic stroke.
    Burnett MM; Zimmermann L; Coralic Z; Quon T; Whetstone W; Kim AS
    Stroke; 2014 Dec; 45(12):3714-6. PubMed ID: 25352486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systemized stroke code significantly reduced time intervals for using intravenous tissue plasminogen activator under magnetic resonance imaging screening.
    Sohn SW; Park HS; Cha JK; Nah HW; Kim DH; Kang MJ; Choi JH; Huh JT
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):465-72. PubMed ID: 25524016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal sustainability of guideline based door-to-needle times for intravenous thrombolysis for acute ischemic stroke.
    Raina A; Trivedi M; Kate M; Kumar L; Erat Sreedharan S; Sylaja PN
    J Clin Neurosci; 2020 Apr; 74():164-167. PubMed ID: 32094070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.